Treatment and follow up data
| Collagenous colitis (n=96) | Lymphocytic colitis (n=80) | |
|---|---|---|
| Treatment initiated | 58% | 45% |
| Type of treatment | ||
| Diet + discontinue medication | 5% | 8% |
| Loperamide | 13% | 8% |
| Cholestyramine | 2% | – |
| Sulphasalazine | 25% | 11% |
| 5-ASA | 4% | 3% |
| Metronidazole | 2% | 6% |
| Corticosteroids | 6% | 3% |
| Duration of treatment (months) | ||
| Mean | 22.1 | 8.8 |
| Median | 5 | 3 |
| p25–p75 | 3–18 | 1–6.7 |
| Range | 0–240 | 0–52 |
| Follow up available | n=69 (72%) | n=39 (49%) |
| Prognosis | ||
| Symptoms gone | 24 (34%) | 23 (59%) |
| On treatment | 7 | 7 |
| No treatment | 17 | 16 |
| Symptoms improved | 28 (40%) | 10 (25%) |
| On treatment | 17 | 9 |
| No treatment | 11 | 1 |
| No change | 17 (26%) | 6 (15%) |
| On treatment | 15 | 4 |
| No treatment | 2 | 2 |
5-ASA, 5-aminosalicylic acid.